OyaGen

About:

OyaGen is a biotechnology company developing novel pharmaceutical therapies that seek to exploit RNA- and DNA-editing enzymes.

Website: http://www.oyageninc.com

Top Investors: Trillium Group, New York State Common Retirement Fund

Description:

OyaGen, Inc., a biotechnology company, engages in discovering, developing, and commercializing novel pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes. Its platform technology encompasses on study of editing enzymes to affect various functions, including antiviral, cancer, immunoglobulin gene rearrangements, inflammation, ion channel function, LDL reduction, neuro-cognitive functions, and red blood cell expression in fetal liver. OyaGen, Inc. was founded in 2003 and is based in Rochester, New York.